PWM
ABBV icon

PBMares Wealth Management’s AbbVie ABBV Stock Holding History

PBMares Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$530K Sell
2,289
-80
-3% -$16.3K 0.09% 110
2025
Q2 		$440K Sell
2,369
-13
-0.5% -$2.42K 0.08% 114
2025
Q1 		$499K Buy
2,382
+1
+0% +$194 0.1% 111
2024
Q4 		$423K Buy
2,381
+1
+0% +$184 0.09% 122
2024
Q3 		$470K Buy
2,380
+501
+27% +$93.5K 0.1% 114
2024
Q2 		$322K Buy
1,879
+255
+16% +$42.2K 0.08% 139
2024
Q1 		$296K Buy
+1,624
New +$280K 0.08% 144
2022
Q2 		– Sell
-1,295
Closed -$210K – 154
2022
Q1 		$210K Buy
+1,295
New +$188K 0.13% 144

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PBMares Wealth Management's ABBV Position: Q3 2025 in Review

PBMares Wealth Management reduced its AbbVie (ABBV) stake by 3.4% in Q3 2025, selling an estimated $16.3K and leaving 2,289 shares worth $530K. The position accounts for 0.09% of the portfolio, ranked #110.

PBMares Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 8 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • PBMares Wealth Management held 2,289 shares of AbbVie worth $530K as of Q3 2025.
  • PBMares Wealth Management sold 80 AbbVie shares in Q3 2025, an estimated $16.3K.
  • AbbVie made up 0.09% of PBMares Wealth Management's portfolio in Q3 2025, its #110 holding.
  • PBMares Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 8 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on PBMares Wealth Management's 13F filing for Q3 2025, filed 27 Oct 2025.